| Catalog Number |
08836981190 |
| Medical Device Problem Codes |
False Negative Result (1225); False Positive Result (1227)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
10/06/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
There was an allegation of questionable elecsys anti-hcv ii results with two patient samples tested on a cobas e 411 analyzer (rack system) compared to a competitor method.Sample 1 (b)(6) 2025): the initial result was 0.066 coi (non-reactive).The repeat result using the vidas system was reactive.The sample was repeated 5-6 times and the results were consistent each time.Sample 2 (b)(6) 2025): the initial result was 21.85 coi (reactive).The repeat result was 21.3 coi (reactive).The repeat result using the vidas system was non-reactive.
|
| |
|
Additional Manufacturer Narrative
|
|
The serial number of the analyzer is (b)(6).The investigation is ongoing.
|
| |
|
Additional Manufacturer Narrative
|
|
Qc and calibration were acceptable.Per the product labeling, "all initially reactive or borderline results giving coi = 0.9 or <1.0 should be rerun in duplicate using the elecsys anti-hcv ii assay.Confirm repeatedly reactive results (coi = 0.90) by independent confirmation methods/according to supplementary algorithms.Confirmatory tests include immunoblot and rna tests.If one or both measurements remain borderline the analysis of a follow-up sample is recommended.For diagnostic purposes, the results should always be assessed in conjunction with the patients' medical history, clinical examination and other findings." the anti-hcv ii assay performs within specification.The investigation determined that a sample specific issue is likely.
|
| |
|
Search Alerts/Recalls
|